CTT Pharmaceutical Holdings, Inc. CTTH
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -89.82% | 107.59% | |||
| Depreciation & Amortization | 0.00% | -73.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -87.87% | 80.41% | |||
| Operating Income | 87.87% | -80.41% | |||
| Income Before Tax | 82.05% | -68.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 82.05% | -68.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 82.05% | -68.39% | |||
| EBIT | 87.87% | -80.41% | |||
| EBITDA | 89.82% | -83.69% | |||
| EPS Basic | 78.57% | -55.56% | |||
| Normalized Basic EPS | 77.78% | -80.00% | |||
| EPS Diluted | 78.57% | -55.56% | |||
| Normalized Diluted EPS | 77.78% | -80.00% | |||
| Average Basic Shares Outstanding | 0.00% | 1.36% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||